Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
DDD00099255
ID: ALA5316214
Chembl Id: CHEMBL5316214
Max Phase: Preclinical
Molecular Formula: C9H18N2O2
Molecular Weight: 186.25
Associated Items:
ID: ALA5316214
Chembl Id: CHEMBL5316214
Max Phase: Preclinical
Molecular Formula: C9H18N2O2
Molecular Weight: 186.25
Associated Items:
Canonical SMILES: CNC(=O)[C@H](CC(C)C)NC(C)=O
Standard InChI: InChI=1S/C9H18N2O2/c1-6(2)5-8(9(13)10-4)11-7(3)12/h6,8H,5H2,1-4H3,(H,10,13)(H,11,12)/t8-/m0/s1
Standard InChI Key: GFQFFCFJVLJXRY-QMMMGPOBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 186.25 | Molecular Weight (Monoisotopic): 186.1368 | AlogP: 0.28 | #Rotatable Bonds: 4 |
Polar Surface Area: 58.20 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.20 | CX Basic pKa: ┄ | CX LogP: -0.09 | CX LogD: -0.09 |
Aromatic Rings: ┄ | Heavy Atoms: 13 | QED Weighted: 0.66 | Np Likeness Score: -0.29 |
1. Izquierdo, M; Lin, D; De Rycker, M. (2023) RapidFire TcLAP Compounds Screening, [10.6019/CHEMBL5305021] |
Source(1):